Pharmacokinetics and clinical effects of cefozopran in pediatric patients

Japanese Journal of Antibiotics

Volumn 49, Issue 1, 1996, Pages 17-33

  Fujii, Ryochi ^a,ab   Abe, Toshiaki ^a   Tajima, Tsuyoshi ^a   Terashima, Itaru ^a   Meguro, Hidenori ^a   Nakazawa, Susumu ^b   Sato, Hajime ^b,ac   Niinou, Kenji ^c   Sunakawa, Keisuke ^d,ab   Yokota, Takao ^d,e   Akita, Hironobu ^e,ad   Iwata, Satoshi ^f   Sato, Yoshitake ^g   Toyonaga, Yoshikiyo ^h   Nakamura, Hironori ⁱ   Seo, Kiwamu ^j   Kawamura, Ken Ichi ^j   Kuno, Kuniyoshi ^k   Ito, Kazue ^k   Iwai, Naoichi ^l   Nakamura, Haruhi ^l   Taneda, Youichi ^m   Sakurai, Minoru ⁿ   Ito, Masahiro ⁿ   Azuma, Eiichi ⁿ   Kamiya, Hitoshi ^o   Kitamura, Kenji ^o   Mikawa, Haruki ^p   Kimata, Hajime ^p   Nishimura, Tadafumi ^q,ab   Tabuki, Kazuo ^q   Aoki, Shigeyuki ^r   Takagi, Michio ^s   Kobayashi, Yohnosuke ^t   Taniuchi, Shoichiro ^t   Kobayashi, Yutaka ^u,ab   Haruta, Tsunekazu ^u   Okura, Kan Etsu ^u   Kuroki, Shigekazu ^u   Nishio, Toshikazu ^u   Matsuda, Hiroshi ^v   Kida, Kaichi ^v   Kainou, Yukikazu ^v   Kurashige, Takanobu ^w   Morita, Hideo ^w   Kuroda, Yasuhiro ^x   Shirakawa, Etsuhisa ^x   Okamoto, Takashi ^y   Sekiguchi, Takanori ^y   Tsuji, Yoshiro ^z   Gondo, Izumi ^z   Kobayashi, Nobuo ^z   Motohiro, Takashi ^aa   Sakata, Yasutaka ^aa   Sasaki, Hirokazu ^aa   Yoshinaga, Youichiro ^aa   Yamada, Shuji ^aa   more..

^a TEIKYO UNIVERSITY   (Japan)

^b SHOWA UNIVERSITY   (Japan)

^c Department of Urology   (Japan)

^d NATIONAL HOSPITAL ORGANIZATION TOKYO MEDICAL CENTER   (Japan)

^e Yamato City Hospital   (Japan)

^f National Hospital Organization Kasumigaura Medical Center   (Japan)

^g Ohta General Hospital   (Japan)

^h Yamanashi Red Cross Hospital   (Japan)

ⁱ SAGAMIHARA NATIONAL HOSPITAL   (Japan)

^j Fuji Municipal Central Hospital   (Japan)

^k ANJO KOSEI HOSPITAL   (Japan)

^l Meitetsu Hospital   (Japan)

^m Chita Municipal Hospital

ⁿ MIE UNIVERSITY   (Japan)

^o Mie Hospital National Sanatorium   (Japan)

^p KYOTO UNIVERSITY   (Japan)

^q OSAKA MEDICAL COLLEGE   (Japan)

^r Hokusetsu Hospital   (Japan)

^s Maizuru Kyosai Hospital   (Japan)

^t KANSAI MEDICAL UNIVERSITY   (Japan)

^u Kobe Chuo Shimin Byoin   (Japan)

^v EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^w KOCHI MEDICAL SCHOOL   (Japan)

^x UNIVERSITY OF TOKUSHIMA   (Japan)

^y TAKAMATSU RED CROSS HOSPITAL   (Japan)

^z NAGASAKI UNIVERSITY   (Japan)

^aa KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^ab Kurume University ^*  (Japan)

^ac University of Tokyo   (Japan)

^ad ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CEFOZOPRAN; CEPHEM DERIVATIVE;

ARTICLE; BACTERIAL MENINGITIS; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; DOSE RESPONSE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG EXCRETION; DRUG HALF LIFE; DRUG PENETRATION; DRUG SAFETY; EOSINOPHILIA; FEMALE; GRAM NEGATIVE INFECTION; GRAM POSITIVE BACTERIUM; HUMAN; INFANT; INTRAVENOUS DRUG ADMINISTRATION; MALE; MINIMUM INHIBITORY CONCENTRATION; PRESCHOOL CHILD; RASH; THROMBOCYTOSIS;

BACTERIA; BACTERIAL INFECTIONS; CEPHALOSPORINS; CHILD; HUMANS;

EID: 0030058972     PISSN: 03682781     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. MIYAKE, A.; Y. YOSHIMURA, M. YAMAOKA, T. NISHIMURA, N. HASHIMOTO & A. IMADA: Studies on condensed-heterocyclic azolium cephalosporins. IV. Synthesis and antibacterial activity of 7β-[2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(Z)-alkoxyiminoacetamido]-3- (condensed-heterocyclic azolium)methyl cephalosporins including SCE-2787. J. Antibiotics 45: 709-720, 1992
2. IWAHI, T.; K. OKONOGI, T. YAMAZAKI, S. SHIKI, M. KONDO, A. MIYAKE & A. IMADA: In vitro and in vivo activities of SCE-2787, a new parenteral cephalosporin with a broad antibacterial spectrum. Antimicro. Agents & Chemother. 36: 1358-1366, 1992
3. NAKAO, M.; Y. NOJI, T. IWAHI & T. YAMAZAKI: Antibacterial properties of SCE-2787, a new cephem antibiotic. J. Antimicro. Chemother. 29: 509-518, 1992
4. Special issue featuring monographs of Chemotherapy. 41 (Suppl. 4), 1993
5. FUJII, R.; T. ABE, T. TAJIMA, I. TERASHIMA, H. MEGURO, S. NAKAZAWA, H. SATO, K. NIINO, K. SUNAKAWA, T. YOKOTA, S. IWATA, H. AKITA, Y. SATO, Y. TOYONAGA, H. NAKAMURA, K. SEO, K. KAWAMURA, K. KUNO, N. IWAI, H. NAKAMURA, Y. TANEDA, M. SAKURAI, E. AZUMA, H. KAMIYA, K. KITAMURA, H. MIKAWA, H. KIMATA, T. NISHIMURA, K. TABUKI, S. AOKI, M. TAKAGI, Y. KOBAYASHI, S. TANIUCHI, Y. KOBAYASHI, T. HARUTA, H. MATSUDA, K. KIDA, Y. KAINOU, T. KURASHIGE, H. MORITA, Y. KURODA, E. SHIRAKAWA, T. OKAMOTO, T. SEKIGUCHI, Y. TUJI, I. GONDO, N. KOBAYASHI, T. MOTOHIRO, N. TAKAJO, M. NAKANO, S. IMAI, H. ARAKI, T. YAMADA, M. HAYASHI, E. ONO, K. KUBOTA, A. KAWAKAMI, T. NISHIYAMA, N. KUDA, K. TOMINAGA, C. YASUOKA, K. SUZUKI, T. FUJIMOTO & H. HAYAKAWA: Basic and clinical investigation of cefozopran (CZOP) in pediatric patients. 41st General Meeting of the Japan Society of Chemotherapy, p.162, June 17-18, 1993 (Tokyo)
6. FUJII, R.; Y. KOBAYASHI, T. NISHIMURA, K. SUNAKAWA, S. IWATA, H. MEGURO, Y. TOYONAGA, H. AKITA, K. KUNO, N. IWAI, T. MOTOHIRO & K. NIINO: Standards for clinical evaluations of antimicrobials in pediatric patients. Jap. J. Antibiotics 46: 411-420, 1993
7. FUJII, R.: Future of antibiotics: In particular, β-lactam antibiotics. Jap. J. Pediatrics 32: 1127-1136, 1979
8. YAMAMOTO, T.; Y. ADACHI, Y. NAGAMINE, M. SUWA & T. NANNO: Phase I trials of cefozopran. Med. Consult. New Remedies 30: 281-304, 1993
9. KOBAYASHI, Y.: Better use of antibiotics in meningitis and brain tumor. Chemotherapy with antimicrobials - How to treat infectious diseases-(Compiled by J. SHIMADA and K. SUNAKAWA), 739-750, Bunkodo, 1992